PCAIGNO Stock Latest News
Private CompaniesAignostics Highlights AI Pathology Platform Advancements at ESMO 20264d agoAIGNO
Private CompaniesAignostics – Weekly Recap2w agoAIGNO
Private CompaniesAignostics Highlights New AI Pathology Suite Built on HETA Platform2w agoAIGNO
Private CompaniesAignostics Launches HETA Clinical to Streamline Pan-Cancer Pathology Workflows2w agoAIGNO
Private CompaniesAignostics Receives AI Startup Award for Ethics-Focused Business Model2w agoAIGNOPrivate CompaniesAignostics Expands Cancer Profiling and Ramps Up Commercial Push in Digital Pathology3w agoAIGNO
Private CompaniesAignostics Boosts Cancer Profiling Capabilities and Steps Up Conference Push4w agoAIGNO
Private CompaniesAignostics Expands Atlas H&E-TME Cancer Coverage and Tumor Microenvironment Detail1M agoAIGNO
Private CompaniesAignostics – Weekly Recap1M agoAIGNO
Private CompaniesAignostics Advances PathoSearch Rollout and Visibility in AI Pathology Market1M agoAIGNO
Private CompaniesAignostics Highlights Early Access Launch of PathoSearch Diagnostic Support Tool1M agoAIGNO
Private CompaniesAignostics Launches Early Access to PathoSearch Visual Search Engine for Pathology1M agoAIGNO
Private CompaniesAignostics Highlights Digital Pathology Tools at European Society of Pathology Congress1M agoAIGNO
Private CompaniesAignostics Showcases Multimodal AI System for Lung Cancer Pathology1M agoAIGNOPrivate CompaniesAignostics Expands AI Pathology Platforms and Showcases New Foundation Model2M agoAIGNO


